Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Current Assets (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Current Assets data on record, last reported at $55.0 million in Q4 2025.

  • For Q4 2025, Current Assets fell 32.77% year-over-year to $55.0 million; the TTM value through Dec 2025 reached $55.0 million, down 32.77%, while the annual FY2025 figure was $55.0 million, 32.77% down from the prior year.
  • Current Assets reached $55.0 million in Q4 2025 per QTTB's latest filing, down from $58.3 million in the prior quarter.
  • Across five years, Current Assets topped out at $262.4 million in Q1 2022 and bottomed at $28.7 million in Q4 2023.
  • Average Current Assets over 5 years is $143.0 million, with a median of $138.0 million recorded in 2024.
  • Peak YoY movement for Current Assets: tumbled 84.14% in 2023, then soared 185.13% in 2024.
  • A 5-year view of Current Assets shows it stood at $191.9 million in 2021, then dropped by 5.68% to $181.0 million in 2022, then crashed by 84.14% to $28.7 million in 2023, then skyrocketed by 185.13% to $81.9 million in 2024, then tumbled by 32.77% to $55.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $55.0 million in Q4 2025, $58.3 million in Q2 2025, and $68.6 million in Q1 2025.